The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases.

[1]  F. Sor,et al.  Molecular characterization of germline NF2 gene rearrangements. , 2000, Genomics.

[2]  A. Asai,et al.  Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. , 1999, Cancer research.

[3]  A. Hagemeijer,et al.  Cutaneous sclerosing perineurioma with cryptic NF2 gene deletion. , 1999, The American journal of surgical pathology.

[4]  C. Bruder,et al.  A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene , 1999, Human Genetics.

[5]  J. Rey,et al.  NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas , 1999, Oncogene.

[6]  F. Sor,et al.  NF2 gene in neurofibromatosis type 2 patients. , 1998, Human molecular genetics.

[7]  B. Scheithauer,et al.  Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases. , 1998, The American journal of surgical pathology.

[8]  M. Nakao,et al.  The involvement of calpain-independent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas , 1998, Nature Medicine.

[9]  D. Evans,et al.  Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. , 1998, Journal of medical genetics.

[10]  M. Miettinen,et al.  Sclerosing perineurioma: a clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults. , 1997, The American journal of surgical pathology.

[11]  D. Louis,et al.  Universal absence of merlin, but not other ERM family members, in schwannomas. , 1997, The American journal of pathology.

[12]  V. Sundaram,et al.  Reduced expression of schwannomin/merlin in human sporadic meningiomas. , 1997, Neurosurgery.

[13]  D. Gutmann,et al.  Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas , 1997, Neurology.

[14]  B. Scheithauer,et al.  Soft-tissue perineurioma. Evidence for an abnormality of chromosome 22, criteria for diagnosis, and review of the literature. , 1997, The American journal of surgical pathology.

[15]  M. Kaiser-Kupfer,et al.  Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. , 1996, American journal of human genetics.

[16]  R. Weksberg,et al.  Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. , 1996, American journal of human genetics.

[17]  D. Barton,et al.  Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. , 1996, Journal of Neurosurgery.

[18]  K. Franssila,et al.  Molecular diagnosis of mantle cell lymphoma in paraffin-embedded tissue. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[19]  B. Scheithauer,et al.  Intraneural perineurioma: A clonal neoplasm associated with abnormalities of chromosome 22 , 1995 .

[20]  K. Hoang-Xuan,et al.  Screening for germ‐line mutations in the NF2 Gene , 1995, Genes, chromosomes & cancer.

[21]  G. Thomas,et al.  Analysis of mutations in the SCH gene in schwannomas , 1994, Genes, chromosomes & cancer.

[22]  Olivier Delattre,et al.  Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas , 1994, Nature Genetics.

[23]  S. Pulst,et al.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.

[24]  J. Haines,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.

[25]  J. Chan,et al.  Perineurioma: An Uncommon Soft Tissue Neoplasm Distinct From Localized Hypertrophic Neuropathy and Neurofibroma , 1992, The American journal of surgical pathology.

[26]  R. Erlandson.  The enigmatic perineurial cell and its participation in tumors and in tumorlike entities. , 1991, Ultrastructural pathology.

[27]  C. Fletcher,et al.  Epithelial membrane antigen expression by the perineurial cell: further studies of peripheral nerve lesions , 1989, Histopathology.

[28]  J. Uitto,et al.  Perineurial cells coexpress genes encoding interstitial collagens and basement membrane zone components , 1989, The Journal of cell biology.

[29]  A. Ariza,et al.  Immunohistochemical Detection of Epithelial Membrane Antigen in Normal Perineurial Cells and Perineurioma , 1988, The American journal of surgical pathology.

[30]  L. Trombetta,et al.  Ultrastructural identification of a benign perineurial cell tumor , 1978, Cancer.

[31]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. R. Hart,et al.  Tumors of the peripheral nervous system. , 1970, Human pathology.

[33]  G. Thomas,et al.  Characterisation of 16 polymorphic markers in the NF2 gene: Application to hemizygosity detection , 1999, Human mutation.

[34]  M. Michal.  Extraneural retiform perineuriomas. A report of four cases. , 1999, Pathology, research and practice.

[35]  木村 麗新.  The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas , 1999 .

[36]  M. Debiec‐Rychter,et al.  Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[37]  D. Lenartz,et al.  Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. , 1995, The American journal of pathology.

[38]  M. Sanson,et al.  The neurofibromatosis type 2 gene is inactivated in schwannomas. , 1994, Human molecular genetics.

[39]  J. Hallervorden.  [Tumors of the nervous system]. , 1951, Strahlentherapie.